Beyond Inc (BYON) concluded trading on Wednesday at a closing price of $11.33, with 6.36 million shares of worth about $72.05 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 88.83% during that period and on July 23, 2025 the price saw a gain of about 6.59%. Currently the company’s common shares owned by public are about 56.83M shares, out of which, 56.73M shares are available for trading.
Stock saw a price change of 54.36% in past 5 days and over the past one month there was a price change of 87.58%. Year-to-date (YTD), BYON shares are showing a performance of -18.84% which increased to 129.82% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $3.54 but also hit the highest price of $15.44 during that period. The average intraday trading volume for Beyond Inc shares is 2.93 million. The stock is currently trading 41.05% above its 20-day simple moving average (SMA20), while that difference is up 62.16% for SMA50 and it goes to 75.13% higher than SMA200.
Beyond Inc (NYSE: BYON) currently have 56.83M outstanding shares and institutions hold larger chunk of about 53.95% of that.
The stock has a current market capitalization of $653.51M and its 3Y-monthly beta is at 2.77. It has posted earnings per share of -$4.66 in the same period. It has Quick Ratio of 0.83 while making debt-to-equity ratio of 0.22. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for BYON, volatility over the week remained 12.27% while standing at 9.41% over the month.
Stock’s fiscal year EPS is expected to rise by 55.61% while it is estimated to increase by 40.09% in next year. EPS is likely to grow at an annualized rate of 46.74% for next 5-years, compared to annual growth of -9.95% made by the stock over the past 5-years.
On October 25, 2024, Needham Reiterated their recommendations, while on October 25, 2024, Maxim Group Reiterated their ratings for the stock with a price target of $26. Stock get an Underperform rating from BofA Securities on October 25, 2024.
